Spirometric changes in obstructive disease: after all, how much is significant?,

OBJECTIVE: To establish the upper limits for changes in FEV(1), slow vital capacity (SVC), FVC, and inspiratory capacity (IC) after placebo administration in patients with airflow obstruction. METHODS: One hundred and two adults with airflow obstruction (FEV(1) = 62 ± 19% of predicted) were included...

Descripción completa

Detalles Bibliográficos
Autores principales: Soares, André Luis Pinto, Pereira, Carlos Alberto de Castro, Rodrigues, Silvia Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075810/
https://www.ncbi.nlm.nih.gov/pubmed/23503486
http://dx.doi.org/10.1590/S1806-37132013000100008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075810/
https://www.ncbi.nlm.nih.gov/pubmed/23503486
http://dx.doi.org/10.1590/S1806-37132013000100008

Ejemplares similares